The HSN (Harmonised System of Nomenclature) code for medicines is used to classify pharmaceutical products under Goods and Services Tax (GST), determine the applicable tax rate and ensure accurate invoicing and tax compliance. Most medicines are classified under HSN Chapter 30, Pharmaceutical Products, with specific headings covering medicaments, vaccines, blood products, surgical materials and other pharmaceutical preparations.
The applicable GST rate depends on the product's HSN classification and the relevant government notifications.
What is the HSN code for medicines?
Chapter 30 of the HSN/customs tariff is broken into headings based on the nature of the product. Here are the details:
|
Description |
HSN code |
|
Glands and other organs, dried, whether or not powdered, for organo-therapeutic uses; extracts of glands, other organs or their secretions for organo-therapeutic uses; heparin and its salts; other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included |
3001 |
|
Extracts of glands or other organs or their secretions |
3001 20 |
|
Liquid liver extracts |
3001 20 10 |
|
Dry liver extracts |
3001 20 20 |
|
Snake venom |
3001 20 30 |
|
Other |
3001 20 90 |
|
Other |
3001 90 |
|
Of human origin |
3001 90 10 |
|
Heparin and its salts |
3001 90 91 |
|
Other |
3001 90 99 |
|
Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions; modified immunological products, whether or not obtained or modified through biotechnological processes; vaccines; toxins; cultures of micro-organisms (excluding yeasts) and similar products |
3002 |
|
Antisera, other blood fractions and immunological products, whether or not modified or obtained through biotechnological processes |
3002 10 |
|
Malaria diagnostic test kits |
3002 11 00 |
|
Antisera and other blood fractions |
3002 12 |
|
Antisera for diphtheria |
3002 12 10 |
|
Antisera for tetanus |
3002 12 20 |
|
Antisera for rabies |
3002 12 30 |
|
Antisera for snake venom |
3002 12 40 |
|
Other antisera and blood fractions |
3002 12 90 |
|
Unmixed immunological products, not put up in measured doses or in forms or packings for retail sale |
3002 13 |
|
Unmixed immunological products, not put up in measured doses or in forms or packings for retail sale |
3002 13 10 |
|
Mixed immunological products, not put up in measured doses or in forms or packings for retail sale |
3002 14 |
|
Mixed immunological products, not put up in measured doses or in forms or packings for retail sale |
3002 14 10 |
|
Immunological products put up in measured doses or in forms or packings for retail sale |
3002 15 00 |
|
Other |
3002 19 00 |
|
Vaccines for human medicine |
3002 20 |
|
Single vaccines |
3002 20 |
|
Single vaccine for cholera and typhoid |
3002 20 11 |
|
Single vaccine for hepatitis |
3002 20 12 |
|
Single vaccine for tetanus |
3002 20 13 |
|
Single vaccine for polio |
3002 20 14 |
|
Single vaccine for tuberculosis |
3002 20 15 |
|
Single vaccine for rabies |
3002 20 16 |
|
Single vaccine for Japanese encephalitis |
3002 20 17 |
|
Single vaccine for whooping cough (pertussis) |
3002 20 18 |
|
Other single vaccines |
3002 20 19 |
|
Mixed vaccines |
3002 20 |
|
Mixed vaccine for diphtheria, pertussis and tetanus (DPT) |
3002 20 21 |
|
Mixed vaccine for diphtheria and tetanus (DT) |
3002 20 22 |
|
Mixed vaccine for measles, mumps and rubella (MMR) |
3002 20 23 |
|
Mixed vaccine for typhoid-paratyphoid (TAB) or typhoid-paratyphoid-cholera (TABC) |
3002 20 24 |
|
Other mixed vaccines |
3002 20 29 |
|
Vaccines for veterinary medicine |
3002 30 00 |
|
Other |
3002 90 |
|
Human blood |
3002 90 10 |
|
Animal blood prepared for therapeutic, prophylactic or diagnostic uses |
3002 90 20 |
|
Cultures of micro-organisms (excluding yeast) |
3002 90 30 |
|
Toxins |
3002 90 40 |
|
Other |
3002 90 90 |
|
Medicaments (excluding goods of headings 3002, 3005 or 3006) consisting of two or more constituents mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale |
3003 |
|
Medicaments containing penicillins or their derivatives with a penicillanic acid structure, or streptomycins or their derivatives |
3003 10 00 |
|
Other medicaments containing antibiotics |
3003 20 00 |
|
Medicaments containing hormones or other products of heading 2937 |
3003 |
|
Medicaments containing insulin |
3003 31 00 |
|
Other medicaments containing hormones or other products of heading 2937 |
3003 39 00 |
|
Medicaments containing alkaloids or their derivatives |
3003 |
|
Medicaments containing ephedrine or its salts |
3003 41 00 |
|
Medicaments containing pseudoephedrine (INN) or its salts |
3003 42 00 |
|
Medicaments containing norephedrine or its salts |
3003 43 00 |
|
Other medicaments containing alkaloids or their derivatives |
3003 49 00 |
|
Medicaments containing active antimalarial principles described in Sub-heading Note 2 to this Chapter |
3003 60 00 |
|
Other medicaments |
3003 90 |
|
Medicaments of the Ayurvedic system |
3003 90 11 |
|
Medicaments of the Unani system |
3003 90 12 |
|
Medicaments of the Siddha system |
3003 90 13 |
|
Medicaments of the Homoeopathic system |
3003 90 14 |
|
Medicaments of the Bio-chemic system |
3003 90 15 |
|
Menthol crystals |
3003 90 21 |
|
Milk of magnesia |
3003 90 22 |
|
Bovine albumin and drugs of animal origin |
3003 90 31 |
|
Merbromine National Formulary XII (Mercurochrome) |
3003 90 32 |
|
Calcium sennoside |
3003 90 33 |
|
Anaesthetic agents used in human or veterinary medicine or surgery |
3003 90 34 |
|
Aluminium hydroxide gel |
3003 90 35 |
|
Ketamine |
3003 90 36 |
|
Other medicaments |
3003 90 90 |
What GST rate applies to medicines?
From 22 September 2025, most medicines will attract 5% GST, following recommendations from the 56th GST Council Meeting. In addition, 37 specified life-saving medicines, including those used to treat cancer, rare diseases and certain chronic conditions, are exempt from GST (Nil rate).
The government retained a 5% GST on most medicines rather than fully exempting them, so manufacturers can continue to claim input tax credit (ITC). This helps reduce production costs and limits the impact of tax costs on medicine prices.
Note: While most medicines now fall under the 5% GST rate, a few pharmaceutical or pharma-adjacent products continue to attract the 18% GST rate. One commonly cited example is nicotine polacrilex gum, which falls outside the standard medicine category.
What are the HSN code requirements on GST invoices?
The HSN code required on a GST invoice depends on your Aggregate Annual Turnover (AATO) in the preceding financial year. Businesses must print the prescribed number of HSN digits on invoices and report them in GST returns in accordance with CBIC Notification No. 78/2020-Central Tax.
|
Aggregate Annual Turnover (AATO) in the preceding FY |
HSN digits required on invoices |
|
Up to ₹5 crore |
4-digit HSN mandatory on B2B invoices; optional on B2C |
|
Above ₹5 crore |
6-digit HSN mandatory on all invoices, B2B and B2C |
|
Exports / imports |
Full 8-digit HSN required to align with customs classification |
A few compliance details that pharma businesses frequently get wrong:
- Table 12 of GSTR-1 is mandatory for all taxpayers: Since 1 January 2024, all registered taxpayers must report HSN-wise details in Table 12 of GSTR-1, regardless of turnover.
- HSN codes must be selected from the GST portal: Under the Phase 3 rollout, manual entry of HSN codes and descriptions is no longer permitted. Taxpayers must select a valid HSN code from the portal's dropdown list, after which the description is auto-populated.
- B2B and B2C supplies are reported separately: Table 12 contains separate sections for B2B and B2C transactions, and the GST portal validates these values against other GSTR-1 tables before submission.
- Composition taxpayers must also report HSN codes: Although composition dealers issue a Bill of Supply instead of a tax invoice, they must comply with the applicable HSN digit requirement based on their turnover.
- HSN digit requirements are based on the previous financial year's AATO: The applicable 4-digit or 6-digit requirement remains unchanged throughout the year, even if turnover changes.
- Table 13 document reporting is mandatory where applicable: Taxpayers reporting B2B or B2C supplies must also complete the required document details in Table 13.
What should pharma businesses check before issuing a GST invoice?
To prepare a GST-compliant invoice for medicines, verify the following before issuing the invoice:
- Use the correct HSN code at the applicable digit level (4, 6 or 8 digits) based on your turnover and the nature of the transaction.
- Verify the applicable GST rate against the specific HSN tariff item. Do not assume all products under the same 4-digit HSN heading attract the same GST rate, as nil-rated, 5% and 18% items may coexist.
- Apply the correct GST type: Charge CGST and SGST for intra-state supplies, and IGST for inter-state supplies and exports.
- Maintain accurate product classification: Record brand status and packaging, as these may affect the classification of Ayurvedic, Unani and Siddha medicines.
- Follow the revised pricing guidance: Following the September 2025 GST rate change, medicines already released into the market before 22 September 2025 did not require MRP re-labelling, provided manufacturers and marketing companies ensured price compliance through approved measures such as supplementary price lists.
- Claim ITC correctly: ITC is generally available on taxable supplies but not on nil-rated or exempt supplies. Businesses making exempt supplies may also need to reverse proportionate ITC on common inputs, where applicable.
What is the penalty for incorrect invoicing
Incorrect invoicing can attract a general penalty of up to ₹25,000 under Section 125 of the CGST Act, depending on the nature of the non-compliance. In addition, using an incorrect HSN code on a B2B invoice can delay or deny the buyer's ITC claim until the error is corrected, even though the mistake originated with the seller.
Conclusion
Using the correct HSN code for medicines is essential for accurate GST classification, invoicing and tax reporting. Regularly reviewing product classifications, applying the correct GST rates and following HSN reporting requirements can help businesses avoid compliance issues, minimise reconciliation errors and maintain accurate financial records.
TallyPrime simplifies HSN-based invoicing, GST reporting and inventory management, enabling pharma businesses to manage compliance efficiently while supporting smoother day-to-day operations.